14S,21R-dihydroxydocosahexaenoic acid remedies impaired healing and mesenchymal stem cell functions in diabetic wounds.
about
Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced TherapyMesenchymal Stem Cells and Cutaneous Wound Healing: Current Evidence and Future PotentialMesenchymal Stem Cell Therapy for Cutaneous WoundsMesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacyMesenchymal Stem Cells as a Prospective Therapy for the Diabetic FootProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeMaresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophagesProresolving lipid mediators and diabetic wound healingIn vitro synthesis of 9,10-dihydroxyhexadecanoic acid using recombinant Escherichia coli.Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls painMaresin-like lipid mediators are produced by leukocytes and platelets and rescue reparative function of diabetes-impaired macrophages.Neuroprotectin/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes.Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions.14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury.Proresolution therapy for the treatment of delayed healing of diabetic wounds.Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury.The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype.Enhanced healing of diabetic wounds by subcutaneous administration of human umbilical cord derived stem cells and their conditioned media.Immunohistological localization of endogenous unlabeled stem cells in wounded skin.DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity.12/15-Lipoxygenase deficiency reduces densities of mesenchymal stem cells in the dermis of wounded and unwounded skinUnsaturated fatty acids induce mesenchymal stem cells to increase secretion of angiogenic mediators.Surgical Denervation of Specific Cutaneous Nerves Impedes Excisional Wound Healing of Small Animal Ear Pinnae.Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease.CYP2E1 oxidises 14(S)-HDHA to 14(S);21(R)-diHDHA and 14(S);21(S)-diHDHAStem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research.
P2860
Q26748517-7AD6F3BB-5B7E-4F15-91E3-F59D9AF40D39Q26822008-B1853206-55CF-4D95-A852-DDB1C8009FF0Q26860887-F39932F8-8527-48E7-AC61-8750E1848F99Q28069171-327FC67B-A4F2-4DB2-81E4-FD1AC16C9927Q28074810-8A3A08D5-8E40-4CC1-94DE-85FA35C8EC9FQ28387661-901BA172-DF2C-4362-84EA-9BDE14476F1CQ28390502-6ACB2BA9-A17D-4661-80C1-F13A96505187Q33683848-F2D964C7-D8F9-4D48-9FE8-F9716065D940Q33706826-536FD4EF-53F6-458E-AB40-AE9DA5F1D7E9Q34130101-BC4C8167-A1C5-44CB-89AC-334D458F9B8AQ34437431-FC769982-239C-49DE-8264-5DA85BF7111CQ34627478-B88B9983-7FA2-453D-847B-449E65E4C300Q35235688-95AAAB77-2ED8-4CC6-AB9A-4B1BACEBF6C8Q35895293-40E7BC99-6AEE-4E9C-B71B-0123F6B0CA5DQ36560613-78473FF6-5ACB-4C20-B993-E8877E28D827Q36572864-233D8002-1E0F-414F-8CA1-2EBBC0B286C7Q36945083-7B76557B-38D4-4787-BAA1-6AA0B450D54BQ37194835-585E0398-0172-458C-9C9F-259227988575Q37664266-E0B7680F-828F-4223-9578-1A8EC48FEF0DQ37671776-F6ACD211-6679-4258-B743-6E0C06FB1A34Q41969776-8526B06D-3635-44C4-954F-3EEC123A910FQ42579200-5A060CF4-9E62-4E8E-BA1E-0CD79AB0A029Q48326701-E14011BC-0F06-4862-906B-C7E6C310D050Q49506046-37BD1183-F279-4A48-96D4-64C0A33CA939Q55216530-BA8B3332-0564-44F2-A25E-50CD3356B8DCQ55669443-AB78CC2E-9299-4869-9BCB-CE7A93C60DB8
P2860
14S,21R-dihydroxydocosahexaenoic acid remedies impaired healing and mesenchymal stem cell functions in diabetic wounds.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@ast
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@en
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@nl
type
label
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@ast
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@en
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@nl
prefLabel
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@ast
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@en
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@nl
P2093
P2860
P356
P1476
14S,21R-dihydroxydocosahexaeno ...... functions in diabetic wounds.
@en
P2093
Haibin Tian
Shraddha P Shah
P2860
P304
P356
10.1074/JBC.M110.100388
P407
P577
2010-11-26T00:00:00Z